Article Details

Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0215, a ...

Retrieved on: 2022-07-29 13:55:53

Tags for this article:

Click the tags to see associated articles and topics

Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0215, a .... View article details on HISWAI: https://pipelinereview.com/index.php/2022072981326/Antibodies/Astria-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-STAR-0215-a-Monoclonal-Antibody-Inhibitor-of-Plasma-Kallikrein-for-Treatment-of-Hereditary-Angioedema.html

Excerpt

STAR-0215 is an investigational monoclonal antibody inhibitor of plasma kallikrein designed to provide long-acting, effective attack prevention for ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up